Oncological safety of skin sparing mastectomy followed by immediate reconstruction for locally advanced breast cancer

Lim, Woosung; Ko, BeomSeok; Kim, Heejung; Lee, Jong Won; Eom, Jin Sup; Son, Byung Ho; Lee, Taik Jong; Ahn, Sei‐Hyun

doi:10.1002/jso.21573

Cited by 64 publications

(52 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, despite the significant disease burden still present at the time of mastectomy in many of our patients, local recurrence rates were not elevated at the 5-year follow-up assessment after TSSM and were comparable with those of other series showing 5-year local recurrence rates after non-TSSM approaches in the range of 5-21 %. [27][28][29] These findings lend support to the use of TSSM in this high-risk population as a strategy for improving aesthetic outcomes without compromising local control, although longer-term follow-up evaluation is needed for further confirmation of this approach.…”

Section: Discussionmentioning

confidence: 88%

Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease?

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 88%

Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease?

et al. 2015

View full text Add to dashboard Cite

show abstract

“…In contrast to mastectomy, IBR has been shown to provide better cosmetic outcome and superior quality of life, without compromising oncological safety (2)(3)(4)(5)(6)(7)(9)(10)(11)(12)(13)(40)(41)(42)(43)(44).…”

Section: Discussionmentioning

confidence: 99%

Factors influencing the decision to pursue immediate breast reconstruction after mastectomy for breast cancer

et al. 2017

View full text Add to dashboard Cite

Background: Immediate breast reconstruction (IBR) after mastectomy has shown to be oncologically safe and to improve quality of life in breast cancer patients. However, most women undergoing mastectomy do not undergo IBR. In this study, we aim to identify breast surgeon-related factors in considering IBR and factors affecting patients' decision to choose for IBR.Methods: Retrospective analysis of the records of breast cancer patients who underwent mastectomy with or without IBR between 2010 and 2013. We documented all information whether or not a patient underwent IBR after mastectomy.Results: Of 437 patients, 97 (22.2%) underwent IBR, 89.8% of which received tissue expanders. Patient who did not undergo IBR had a higher age (62.2 versus 51.9 years, P<0.001) and higher body mass index (BMI) (27.0 versus 24.3, P<0.001). Hundred three patients declined IBR, mainly because considering reconstruction as too much trouble. In 128 cases the breast surgeon did not offer IBR, mostly because of the predicted need for post mastectomy radiation. Approximately 11% of the patients were not informed about IBR.Conclusions: Anticipated radiation therapy, higher age and higher BMI were important breast surgeonrelated factors in refraining from IBR. Almost one third of all patients declined IBR. In almost 10% of all patients, IBR was not discussed.Keywords: Breast neoplasms; breast reconstruction; decision making; mammaplasty; mastectomy Submitted Aug 11, 2016. Accepted for publication Oct 27, 2016Oct 27, . doi: 10.21037/gs.2016 View this article at: http://dx.doi.org/10.21037/gs.2016.11.11 44 Weenk et al. Decision-making process in IBR © Gland Surgery. All rights reserved.Gland Surg 2017;6(1):43-48 gs.amegroups.com States. In 2000, 12.9% of all mastectomies performed in the United States were combined IBR, increasing to 36.3% in 2009 (15). The United Kingdom Association of Breast Surgery recommends that any patient in which IBR is oncologically safe should have the possibility to choose for IBR (16). Dutch guidelines state IBR has a slight preference instead of delayed reconstruction and that every patient considered for mastectomy has to be informed about reconstructive options (17). However, despite the evidence and recommendations, almost two thirds of the mastectomies are still performed without IBR. We asked ourselves if there are elements in the pre-operative process that could facilitate or impede the choice for IBR. The major objective of this study was to investigate the decision-making process on whether or not a patient undergoes immediate reconstruction after mastectomy. In this study we focused on the role of patient as well as the role of the breast surgeon. MethodsWe investigated all electronic patient files of women diagnosed with DCIS or invasive carcinoma between 2010 and 2013, and underwent a mastectomy at the Canisius Wilhelmina Breast Center in Nijmegen, the Netherlands. Patients who underwent prophylactic mastectomy were excluded. IBR is defined as mastectomy and reconstruction performed on the same day. ...

show abstract

“…Only a single study also evaluated other abdominal flaps (i.e., DIEP and SIEA flap reconstruction). 17 All were cohort trials, mostly conducted in North America (n = 11), 9,13,14,17,18,[24][25][26][27][28][29] with one each from Croatia/Austria, 15 Italy, 30 and the United Kingdom. 16 The mean follow-up period ranged from 6 months 15 to 60.2 months 18 ( Table 2).…”

Section: Description Of the Included Studiesmentioning

confidence: 99%

Safety of Tissue Expander/Implant versus Autologous Abdominal Tissue Breast Reconstruction in Postmastectomy Breast Cancer Patients

Tsoi

Ziolkowski

Thoma

et al. 2014

Plastic and Reconstructive Surgery

106

View full text Add to dashboard Cite

show abstract

Oncological safety of skin sparing mastectomy followed by immediate reconstruction for locally advanced breast cancer

Abstract: Our study demonstrates that SSM followed by immediate reconstruction is oncologically safe for locally advanced breast cancer.

Cited by 64 publications

References 19 publications

Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease?

Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease?

Factors influencing the decision to pursue immediate breast reconstruction after mastectomy for breast cancer

Safety of Tissue Expander/Implant versus Autologous Abdominal Tissue Breast Reconstruction in Postmastectomy Breast Cancer Patients

Contact Info

Product

Resources

About